Departments of1Neurosurgery and.
2Department of Neurosurgery, Gates Vascular Institute at Kaleida Health, Buffalo.
J Neurosurg. 2022 Apr 1;137(6):1751-1757. doi: 10.3171/2022.2.JNS22105. Print 2022 Dec 1.
The paradigm for intracranial aneurysm (IA) treatment is shifting toward a hybrid approach involving open and endovascular techniques. The authors chronicled the evolution of IA treatment by retrospectively examining a large series of IA cases treated by a single dual-trained neurosurgeon, focusing on evolving technology relative to the choice of treatment options, perioperative morbidity, and mortality.
The aneurysm database at the authors' institution was searched to identify consecutive patients treated with endovascular or open microsurgical approaches by one neurosurgeon during an 18-year time span. Patients were included regardless of IA rupture status, location or morphology, or treatment modality. Data collected were baseline clinical characteristics, aneurysm size, treatment modality, operative complications, in-hospital mortality, and retreatment rate.
A total of 1858 patients with 2002 IA treatments were included in the study. Three-hundred fifty IAs (17.5%) were ruptured. Open microsurgery was performed in 504 aneurysms (25.2%) and endovascular surgery in 1498 (74.8%). Endovascular IA treatments trended toward a growing use of flow diversion during the last 11 years. In-hospital mortality was 1.7% overall, including 7.0% in ruptured and 0.5% in unruptured cases. The overall complication rate was 3.3%, including 3.4% for microsurgical cases and 3.3% for endovascular cases. The rate of retreatment was 3.6% after clipping and 10.7% for endovascular treatment.
This study demonstrates complementary use of open and endovascular approaches for IA treatment. By customizing treatment to the patient, comparable rates of procedural complications, mortality, and retreatment were achieved for both endovascular and microsurgical approaches.
颅内动脉瘤(IA)的治疗模式正在向开放和血管内技术相结合的混合方法转变。作者通过回顾性检查一位双培训神经外科医生治疗的大量 IA 病例,记录了 IA 治疗的演变,重点是治疗选择、围手术期发病率和死亡率方面的不断发展的技术。
作者所在机构的动脉瘤数据库被搜索,以确定在 18 年的时间跨度内,一位神经外科医生通过血管内或开放显微手术方法治疗的连续患者。无论 IA 是否破裂、位置或形态、或治疗方式如何,均纳入患者。收集的数据包括基线临床特征、动脉瘤大小、治疗方式、手术并发症、住院死亡率和再治疗率。
共有 1858 名患者的 2002 个 IA 治疗纳入了研究。350 个 IA(17.5%)破裂。开放显微手术治疗 504 个动脉瘤(25.2%),血管内手术治疗 1498 个(74.8%)。在过去的 11 年中,血管内 IA 治疗中血流转向的应用呈增长趋势。总的住院死亡率为 1.7%,包括破裂组的 7.0%和未破裂组的 0.5%。总的并发症发生率为 3.3%,包括显微手术组的 3.4%和血管内手术组的 3.3%。夹闭后再治疗率为 3.6%,血管内治疗为 10.7%。
本研究表明,开放和血管内方法可互补用于 IA 治疗。通过根据患者的情况定制治疗方案,血管内和显微手术方法的手术并发症、死亡率和再治疗率相当。